Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.

Am J Hum Genet 2012 May 19;90(5):796-808. Epub 2012 Apr 19.

Division of Human Genetics, Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA.

Psoriasis is a common inflammatory disorder of the skin and other organs. We have determined that mutations in CARD14, encoding a nuclear factor of kappa light chain enhancer in B cells (NF-kB) activator within skin epidermis, account for PSORS2. Here, we describe fifteen additional rare missense variants in CARD14, their distribution in seven psoriasis cohorts (>6,000 cases and >4,000 controls), and their effects on NF-kB activation and the transcriptome of keratinocytes. There were more CARD14 rare variants in cases than in controls (burden test p value = 0.0015). Some variants were only seen in a single case, and these included putative pathogenic mutations (c.424G>A [p.Glu142Lys] and c.425A>G [p.Glu142Gly]) and the generalized-pustular-psoriasis mutation, c.413A>C (p.Glu138Ala); these three mutations lie within the coiled-coil domain of CARD14. The c.349G>A (p.Gly117Ser) familial-psoriasis mutation was present at a frequency of 0.0005 in cases of European ancestry. CARD14 variants led to a range of NF-kB activities; in particular, putative pathogenic variants led to levels >2.5× higher than did wild-type CARD14. Two variants (c.511C>A [p.His171Asn] and c.536G>A [p.Arg179His]) required stimulation with tumor necrosis factor alpha (TNF-α) to achieve significant increases in NF-kB levels. Transcriptome profiling of wild-type and variant CARD14 transfectants in keratinocytes differentiated probably pathogenic mutations from neutral variants such as polymorphisms. Over 20 CARD14 polymorphisms were also genotyped, and meta-analysis revealed an association between psoriasis and rs11652075 (c.2458C>T [p.Arg820Trp]; p value = 2.1 × 10(-6)). In the two largest psoriasis cohorts, evidence for association increased when rs11652075 was conditioned on HLA-Cw*0602 (PSORS1). These studies contribute to our understanding of the genetic basis of psoriasis and illustrate the challenges faced in identifying pathogenic variants in common disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajhg.2012.03.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376540PMC
May 2012
90 Reads

Publication Analysis

Top Keywords

card14
9
variants
9
pathogenic mutations
8
psoriasis cohorts
8
pathogenic variants
8
card14 encoding
8
variants led
8
card14 variants
8
variants card14
8
putative pathogenic
8
psoriasis
6
led levels
4
levels >25×
4
ancestry card14
4
nf-kb activities
4
>25× higher
4
led range
4
range nf-kb
4
activities putative
4
c511c>a [phis171asn]
4

Similar Publications